Sedation Safety During Minimally Invasive Heart Valve Procedure
Part of Heart & circulation, Lungs & breathing clinical trials.
This study examines how a specific sedative medication (dexmedetomidine) affects breathing and heart function during a minimally invasive procedure to replace a faulty heart valve. Researchers want to ensure the sedation is safe and effective for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older
- You are scheduled for transfemoral TAVI (a minimally invasive heart valve replacement procedure)
- You will receive sedation (twilight sleep) rather than general anesthesia during the procedure
- You speak French well enough to complete mental clarity tests after the procedure
- You do not have medical conditions that make dexmedetomidine unsafe for you
- Your heart rhythm and blood pressure are stable enough for this procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how well patients recover after a minimally invasive heart valve procedure (TAVR) when given different types of sedation. The goal is to find which sedation approach helps patients feel better and recover faster after the procedure.
This trial compares two sedation and pain relief medicine combinations (dexmedetomidine vs. midazolam-fentanyl) to see which works better for people having planned heart valve surgery.
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
This trial tests whether a sedating medicine called dexmedetomidine can reduce the risk of “delirium” (sudden confusion) in the intensive care unit after open-heart surgery. If you’re having certain heart operations, it may help protect your thinking and alertness during recovery.
This trial tests whether a drug called dexmedetomidine can help prevent a common heart rhythm problem (atrial fibrillation) that can happen after mitral valve surgery. If you are having mitral valve surgery and are at risk for this arrhythmia, this could help you recover more smoothly.
This trial tests whether a newer sedative (remimazolam) or a commonly used one (dexmedetomidine) is better at preventing delirium after planned heart surgery that requires a heart-lung machine. If you are having elective coronary bypass or valve surgery, you may be able to join.
Hear when a new TAVI(Transcatheter Aortic Valve Implantation) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.